Laurence H. Beck, MD, PhD

Associate Professor, Medicine

Laurence Beck
(617) 638-7330
650 Albany St Evans Biomed Research Ctr


Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center


  • Harvard Medical School, MD
  • Harvard University, PhD
  • Princeton University, BA


  • Published on 10/26/2017

    Larsen CP, Trivin-Avillach C, Coles P, Collins AB, Merchant M, Ma H, Wilkey DW, Ambruzs JM, Messias NC, Cossey LN, Rosales IA, Wooldridge T, Walker PD, Colvin RB, Klein J, Salant DJ, Beck LH. LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. J Am Soc Nephrol. 2017 Oct 26. PMID: 29074737.

    Read at: PubMed
  • Published on 7/3/2017

    Beck LH. PLA2R and THSD7A: Disparate Paths to the Same Disease? J Am Soc Nephrol. 2017 Sep; 28(9):2579-2589. PMID: 28674044.

    Read at: PubMed
  • Published on 2/4/2017

    Burbelo PD, Beck LH, Waldman M. Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy. J Immunol Methods. 2017 May; 444:17-23. PMID: 28167276.

    Read at: PubMed
  • Published on 9/21/2016

    Havasi A, Lu W, Cohen HT, Beck L, Wang Z, Igwebuike C, Borkan SC. Blocking peptides and molecular mimicry as treatment for kidney disease. Am J Physiol Renal Physiol. 2017 Jun 01; 312(6):F1016-F1025. PMID: 27654896.

    Read at: PubMed
  • Published on 7/19/2016

    Hoxha E, Beck LH, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. J Am Soc Nephrol. 2017 Feb; 28(2):520-531. PMID: 27436855.

    Read at: PubMed
  • Published on 6/11/2016

    Waldman M, Beck LH, Braun M, Wilkins K, Balow JE, Austin HA. Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab. Kidney Int Rep. 2016 Jul; 1(2):73-84. PMID: 27942609.

    Read at: PubMed
  • Published on 4/13/2016

    Francis JM, Beck LH, Salant DJ. Membranous Nephropathy: A Journey From Bench to Bedside. Am J Kidney Dis. 2016 Jul; 68(1):138-47. PMID: 27085376.

    Read at: PubMed
  • Published on 3/11/2016

    Gupta G, Fattah H, Ayalon R, Kidd J, Gehr T, Quintana LF, Kimball P, Sadruddin S, Massey HD, Kumar D, King AL, Beck LH. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation. Clin Transplant. 2016 Apr; 30(4):461-9. PMID: 26854647.

    Read at: PubMed
  • Published on 2/26/2016

    El-Husseini A, Saxon D, Jennings S, Cornea V, Beck L, Sawaya BP. Idiopathic Membranous Nephropathy: Diagnostic and Therapeutic Challenges. Am J Nephrol. 2016; 43(2):65-70. PMID: 26914654.

    Read at: PubMed
  • Published on 2/5/2016

    Larsen CP, Cossey LN, Beck LH. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. Mod Pathol. 2016 Apr; 29(4):421-6. PMID: 26847174.

    Read at: PubMed

View 40 more publications: View full profile at BUMC

View all profiles